BB

BZ Bank

Europe, Solothurn, Switzerland, Wiler

Description

BZ Bank invests in early stage and later stage ventures and is a Wiler-based banking firm.

Investor Profile

BZ Bank has made 5 investments, with 0 in the past 12 months and 100% as lead.

Stage Focus

  • Series B (40%)
  • Series Unknown (40%)
  • Series A (20%)

Country Focus

  • Switzerland (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Pharmaceutical
  • Health Care
  • Financial Services
  • Information Technology
  • Software
  • Wealth Management
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BZ Bank frequently co-invest with?

IF
Europe, Basel-Landschaft, Switzerland, Bubendorf
Co-Investments: 1
LI
Europe, Geneve, Switzerland, Geneva
Co-Investments: 2
Varuma
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Aravis Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 2
BB Biotech Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Pictet Private Equity Investors S.A.
Europe, Geneve, Switzerland, Geneva
Co-Investments: 2

What are some of recent deals done by BZ Bank?

additiv

Zürich, Zurich, Switzerland

additiv is a provider in the field of digitization of banks, asset managers and insurers.

Financial ServicesInformation TechnologySoftwareWealth Management
Series UnknownMay 17, 2017
Amount Raised: $21,445,356
NovImmune

Plan-les-ouates, Geneve, Switzerland

NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.

BiotechnologyMedicalPharmaceutical
Series BDec 17, 2010
Amount Raised: $20,694,165
NovImmune

Plan-les-ouates, Geneve, Switzerland

NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.

BiotechnologyMedicalPharmaceutical
Series UnknownMay 12, 2009
Amount Raised: $54,800,000
Pevion Biotech

Bern, Bern, Switzerland

Pevion Biotech is a biotechnology company that uses its proprietary technology platforms.

BiotechnologyHealth CareMedical
Series AAug 13, 2007
Amount Raised: $29,160,000
NovImmune

Plan-les-ouates, Geneve, Switzerland

NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.

BiotechnologyMedicalPharmaceutical
Series BJun 1, 2006
Amount Raised: $46,000,000